Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu

Policy Updates

Check insights and updates from APIC!

OSHA Non-Healthcare Employer Vaccine Requirement Withdrawn
02/11/2022
OSHA Non-Healthcare Employer Vaccine Requirement Withdrawn

1/26/22 — Following the recent Supreme Court ruling striking down the OSHA COVID-19 Vaccination and Testing Emergency Temporary Standard (ETS), OSHA is withdrawing the ETS effective January 26. Neither this OSHA ETS nor the Supreme Court ruling pertained to healthcare personnel vaccination; however, healthcare personnel employed by facilities receiving Medicare/Medicaid reimbursement are required to receive COVID-19 … Continued

Read More
CMS Updates Guidance for COVID-19 HCP Vaccination Rule Following Supreme Court Decision
02/11/2022
CMS Updates Guidance for COVID-19 HCP Vaccination Rule Following Supreme Court Decision

1/14/22 — Following the January 13 Supreme Court decision upholding the CMS Omnibus COVID-19 Health Care Staff Vaccination interim final rule, CMS updated its guidance and survey procedures for assessing and maintaining compliance with these regulatory requirements. This guidance specifically applies to the following states: Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, … Continued

Read More
Supreme Court Rules on COVID-19 Vaccine Mandates
02/11/2022
Supreme Court Rules on COVID-19 Vaccine Mandates

1/13/22 — The U.S. Supreme Court ruled in two different cases to uphold the CMS COVID-19 vaccination mandate for healthcare personnel and to strike down the OSHA COVID-19 vaccination and testing emergency temporary standard (ETS). In a 5-4 decision the case of Biden v. Missouri, the Court ruled that CMS was within its authority in imposing the … Continued

Read More
HHS Renews COVID-19 PHE
02/11/2022
HHS Renews COVID-19 PHE

1/14/22 — HHS Secretary Xavier Becerra renewed the COVID-19 public health emergency (PHE), effective January 16, 2022. A PHE remains in effect for 90 days but may be extended. Read the secretary’s statement.

Read More
CMS Suppresses NHSN HAI Measures Due to COVID Pandemic
02/11/2022
CMS Suppresses NHSN HAI Measures Due to COVID Pandemic

1/13/22 — In the FY 2022 Hospital Inpatient Prospective Payment System (IPPS) final rule, CMS implemented a “Measure Suppression Policy.” Under this policy, CMS will not use certain measures (including NHSN HAI measures) from the Q3 and Q4 2020 reporting periods for performance scoring in the Hospital-Acquired Condition (HAC) Reduction Program and the Hospital Value-Based … Continued

Read More
CMS Updates Nursing Home Visitation FAQs
02/11/2022
CMS Updates Nursing Home Visitation FAQs

1/11/22 — CMS has updated its “Nursing Home Visitation FAQs” document to provide additional clarification on its revised guidance issued in November 2021. The key message is that visitation must be permitted at all times with very limited and rare exceptions, in accordance with residents’ rights. Nursing homes should enable visitation following these three key points: • Adhere to … Continued

Read More
NIOSH Rescinds Approvals for ALG Health Respirators
02/11/2022
NIOSH Rescinds Approvals for ALG Health Respirators

1/11/22 — NIOSH has honored a request by ALG Health to voluntarily rescind ALL NIOSH respirator approvals issued to ALG Health. As of January 6, 2022, any respirator marked with a NIOSH approval label indicating any of the following approval numbers is no longer NIOSH-approved. TC-84A-9259, TC-84A -9262, TC-84A-9270, TC-84A-9271, TC-84A-9273, TC-84A-9274, TC-84A-9275, TC-84A-9280, TC-84A-9281, TC-84A-9282, TC- 84A-9288, … Continued

Read More
FDA/CDC Shorten Booster Interval for Moderna COVID-19 Vaccine
02/11/2022
FDA/CDC Shorten Booster Interval for Moderna COVID-19 Vaccine

1/7/22 — The FDA amended the EUA for the Moderna COVID-19 vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.The CDC followed suit by updating its recommendation for getting the a Moderna … Continued

Read More
FDA Stop Use Order for LuSys Lab COVID-19 Test
02/11/2022
FDA Stop Use Order for LuSys Lab COVID-19 Test

1/11/22 — The FDA is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test. The performance of these tests has not been adequately established and the FDA believes there is likely a high risk of false results when using these tests. Neither test has been authorized, cleared, … Continued

Read More